Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Out with Cancer: LGBTQI+ experiences of cancer survivorship and care
Do we understand the needs of lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI+) cancer…
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among…
Medical trial aims to identify those at risk of heart damage following cancer treatment
The Murdoch Children’s Research Institute (MCRI) is recruiting patients for a new national trial aiming…
Australian receives global recognition for pioneering prostate cancer research
A breakthrough technique utilising Magnetic Resonance Imaging (MRI) is set to optimise the prostate cancer diagnostic and management process. Led…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.